(Q43848815)

English

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

scientific article published on 26 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Claudia Hube-Magg

6

object named as

Claudia Hube-Magg

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

11

object named as

Hans Heinzer

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

16

object named as

Sarah Minner

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

15

object named as

Guido Sauter

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Thorsten Schlomm

17

object named as

Thorsten Schlomm

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

5

object named as

Stefan Steurer

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Waldemar Wilczak

12

object named as

Waldemar Wilczak

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

13

object named as

Martina Kluth

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Maria Christina Tsourlakis

18

object named as

Maria Christina Tsourlakis

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jakob R Izbicki

14

object named as

Jakob R Izbicki

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Georg Anton Salomon

10

object named as

Georg Salomon

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Katharina Grupp

1

object named as

Katharina Grupp

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

8

object named as

Lia Burkhardt

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

object named as

Hüseyin Sirma

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

7

object named as

Kristina Prien

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Karolina Jedrzejewska

9

object named as

Karolina Jedrzejewska

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Mareike Habermann

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

26 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

96-106

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Transport of proteins and RNAs in and out of the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Importin KPNA2, NBS1, DNA repair and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor Prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Integrative genomic profiling of human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

The genomic complexity of primary human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Tissue microarray sampling strategy for prostate cancer biomarker analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Structural basis for the nuclear import of the human androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Differential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequences

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Role of the TMPRSS2-ERG gene fusion in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Wnt signaling from development to disease: insights from model systems

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Activation of the Ran GTPase is subject to growth factor regulation and can give rise to cellular transformation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

TOR kinase and Ran are downstream from PI3K/Akt in H2O2-induced mitosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

Detection ofERGgene rearrangements andPTENdeletions in unsuspected prostate cancer of the transition zone

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

21 January 2018

KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of p53 alterations in surgically treated prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Recipient block TMA technique

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked heterogeneity of ERG expression in large primary prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2013.127

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

release_rc4yeohxcrfhhemqe7sn7myxa4

1 reference

https://api.fatcat.wiki/v0/release/rc4yeohxcrfhhemqe7sn7myxa4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43848815&oldid=2206292665"